Post on 19-Jan-2016
EC actions against the rising threats from Antimicrobial Resistance
Workshop on Antimicrobial Resistance
Koen Van Dyck Head of Unit
SANTE DDG2.G4: Food, Alert system and Training Directorate General Health & Food Safety (DG SANTE)
European Commission
16-17 November 2015 – Brussels
According to data from 2011, 25 000 patients die annually as a result of infections caused by resistant bacteria in the EU. The costs incurred by drug resistant infections amount to an estimated €1.5 billion annually, due to increases in healthcare expenditure costs and productivity losses.
http://www.compoundchem.com/2014/09/08/antibiotics/
AMR is a major European and global societal problem
Decision-makers Scientific advice
CHVPCVMPESVAC
Committees
Scientific committees
SCENIHR
EARS-NetESAC-Net
Networks
Regulations; Directives; EC communications /
decisions; Council conclusions / resolutions /
recommendations
Guidelines, technical reports, scientific advice,
recommendations
Guidelines, reports
Codex Alimentarius
International organisations
AMR a public health priority
Some actions taken so far:
Ban on the use of AM for growth promotion (2006)
Monitoring AMR and use of antimicrobials(EU agencies: EFSA, EMA, ECDC)
International activities (TATFAR, Codex, OIE)
Research
Scientific opinions, data on monitoring
Not enough, further action needed !
55
AMR a public health priority!
6
COM (2011) 748 – 17 Nov 2011• 5 year action plan• Holistic approach• 7 key areas• 12 concrete actions
1. Appropriate use
4. Prevention of infections
6. New antibiotics
9. Surveillance
The 12 actions
Human
2 & 3. Appropriate use
5. Prevention of infections
7. Need for new antibiotics
10. Surveillance
Veterinary
8. International cooperation
11. Research & Innovation
12. Communication, education
7
A. Appropriate use of antimicrobialsAction nº1: Strengthen the promotion of the appropriate use of antimicrobials in human medicine in all Member States
Action nº2: Strengthen the regulatory framework on veterinary medicines and on medicated feed
Action nº3: Introduce recommendations for prudent use in veterinary medicine
B. Prevent microbial infections & spread
Action nº4: Strengthen infection prevention and control in healthcare settings
Action nº5: Adoption of a proposal for an EU Animal Health Law
C. Develop new effective AM or alternatives for treatment
Action nº6: Promote unprecedented collaborative research
Action nº7: Promote efforts to analyse need for new antibiotics into veterinary medicine
D. Join forces with international partners
Action nº8: Develop and / or strengthen multilateral and bilateral commitments for the prevention and control of AMR
E. Monitoring and surveillanceAction nº9: Strengthen surveillance systems on AMR and antimicrobial consumption in human medicine
Action nº10: Strengthen surveillance systems on AMR and antimicrobial consumption in animal medicine
F. Additional Research and InnovationAction nº11: Reinforce and co-ordinate research efforts. Innovation.
G. Communication, education and training
Action nº12: Survey and comparative effectiveness research
Next steps
• Dedicated webpage http://ec.europa.eu/dgs/health_food-safety/amr/index_en.htm
• AMR progress report http://ec.europa.eu/health/antimicrobial_resistance/docs/2015_amr_progress_report_en.pdf
• AMR Roadmap http://ec.europa.eu/health/antimicrobial_resistance/docs/roadmap_amr_en.pdf
• Ex-post evaluation (February 2016)
Concluding remarks
• AMR remain a top priority for European Commission to lead at EU and work at global level
• Ongoing evaluation of the EC Action Plan – basis to decide on the follow-up
• Importance of concrete actions and implementation of the action plans by all stakeholders and Member States.
Thank you for your attention